Search

everythinglearnresearchcommunity

for

Search:↓

Combining 5% minoxidil with platelet-rich plasma is more effective for hair loss than minoxidil alone.

A woman was allergic to 5% minoxidil, with stronger reactions to higher concentrations.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

Stopping imipramine reduced the woman's hair loss.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Retinoids can change the hair growth cycle by extending the growth phase and shortening the rest phase.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

Genetic variants affect minoxidil hair loss treatment success.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Higher minoxidil dose helps hair growth in non-responders without side effects.

Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

5% topical minoxidil effectively treated a boy's congenital triangular alopecia without side effects.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Topical booster improves hair loss treatment effectiveness.

A patient with complete hair loss regrew all her hair using tofacitinib.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

The mouse model could be useful for baldness research and testing treatments like testosterone, cyproterone acetate, and minoxidil.

Allergic reactions to minoxidil may be due to the propylene glycol it is mixed with, not the minoxidil itself.

Minoxidil activation by hair enzymes predicts treatment success for female hair loss.